Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Inspire Veterinary Partners ( (IVPR) ).
On February 26, 2026, Inspire Veterinary Partners Inc. announced that director Erinn Thomas-Mackey resigned from its board of directors, effective immediately. The company stated that her departure did not arise from any disagreement over operations, policies or practices, suggesting a routine governance change with limited immediate impact on its strategic direction or stakeholder relations.
The most recent analyst rating on (IVPR) stock is a Sell with a $0.03 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners stock, see the IVPR Stock Forecast page.
Spark’s Take on IVPR Stock
According to Spark, TipRanks’ AI Analyst, IVPR is a Underperform.
The score is driven primarily by weak financial performance (negative profitability, high leverage, and negative operating/free cash flow) and bearish technical signals (below major moving averages with negative MACD). Additional downside risk comes from Nasdaq delisting and OTCQB move, while valuation is difficult to support due to a negative P/E and no dividend yield data.
To see Spark’s full report on IVPR stock, click here.
More about Inspire Veterinary Partners
Inspire Veterinary Partners Inc. operates in the veterinary services industry, focusing on providing medical care and related services for companion animals through a network of veterinary practices. The company’s governance structure includes a board of directors overseeing strategic decisions and corporate policies in support of its clinical operations.
Average Trading Volume: 137,106,211
Technical Sentiment Signal: Sell
Current Market Cap: $353.7K
For an in-depth examination of IVPR stock, go to TipRanks’ Overview page.